Literature DB >> 22231568

Evaluation of TRAF6 in a large multiancestral lupus cohort.

Bahram Namjou1, Chan-Bum Choi, Isaac T W Harley, Marta E Alarcón-Riquelme, Jennifer A Kelly, Stuart B Glenn, Joshua O Ojwang, Adam Adler, Kwangwoo Kim, Caroline J Gallant, Susan A Boackle, Lindsey A Criswell, Robert P Kimberly, Elizabeth E Brown, Jeffrey Edberg, Graciela S Alarcón, Anne M Stevens, Chaim O Jacob, Gary S Gilkeson, Diane L Kamen, Betty P Tsao, Juan-Manuel Anaya, Eun-Mi Kim, So-Yeon Park, Yoon-Kyoung Sung, Joel M Guthridge, Joan T Merrill, Michelle Petri, Rosalind Ramsey-Goldman, Luis M Vilá, Timothy B Niewold, Javier Martin, Bernardo A Pons-Estel, Timothy J Vyse, Barry I Freedman, Kathy L Moser, Patrick M Gaffney, Adrienne H Williams, Mary E Comeau, John D Reveille, Changwon Kang, Judith A James, R Hal Scofield, Carl D Langefeld, Kenneth M Kaufman, John B Harley, Sang-Cheol Bae.   

Abstract

OBJECTIVE: Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease with significant immune system aberrations resulting from complex heritable genetics as well as environmental factors. We undertook to study the role of TRAF6 as a candidate gene for SLE, since it plays a major role in several signaling pathways that are important for immunity and organ development.
METHODS: Fifteen single-nucleotide polymorphisms (SNPs) across TRAF6 were evaluated in 7,490 SLE patients and 6,780 control subjects from different ancestries. Population-based case-control association analyses and meta-analyses were performed. P values, false discovery rate q values, and odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated.
RESULTS: Evidence of associations was detected in multiple SNPs. The best overall P values were obtained for SNPs rs5030437 and rs4755453 (P = 7.85 × 10(-5) and P = 4.73 × 10(-5) , respectively) without significant heterogeneity among populations (P = 0.67 and P = 0.50, respectively, in Q statistic). In addition, SNP rs540386, which was previously reported to be associated with rheumatoid arthritis (RA), was found to be in linkage disequilibrium with these 2 SNPs (r(2) = 0.95) and demonstrated evidence of association with SLE in the same direction (meta-analysis P = 9.15 × 10(-4) , OR 0.89 [95% CI 0.83-0.95]). The presence of thrombocytopenia improved the overall results in different populations (meta-analysis P = 1.99 × 10(-6) , OR 0.57 [95% CI 0.45-0.72], for rs5030470). Finally, evidence of family-based association in 34 African American pedigrees with the presence of thrombocytopenia was detected in 1 available SNP (rs5030437) with a Z score magnitude of 2.28 (P = 0.02) under a dominant model.
CONCLUSION: Our data indicate the presence of association of TRAF6 with SLE, consistent with the previous report of association with RA. These data provide further support for the involvement of TRAF6 in the pathogenesis of autoimmunity.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22231568      PMCID: PMC3380425          DOI: 10.1002/art.34361

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  30 in total

1.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

2.  WHAP: haplotype-based association analysis.

Authors:  Shaun Purcell; Mark J Daly; Pak C Sham
Journal:  Bioinformatics       Date:  2006-11-21       Impact factor: 6.937

3.  PLINK: a tool set for whole-genome association and population-based linkage analyses.

Authors:  Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

4.  Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus.

Authors:  Kenneth M Kaufman; Jennifer A Kelly; Billy J Herring; Adam J Adler; Stuart B Glenn; Bahram Namjou; Summer G Frank; Sarah L Dawson; Gail R Bruner; Judith A James; John B Harley
Journal:  Arthritis Rheum       Date:  2006-08

5.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.

Authors:  Geoffrey Hom; Robert R Graham; Barmak Modrek; Kimberly E Taylor; Ward Ortmann; Sophie Garnier; Annette T Lee; Sharon A Chung; Ricardo C Ferreira; P V Krishna Pant; Dennis G Ballinger; Roman Kosoy; F Yesim Demirci; M Ilyas Kamboh; Amy H Kao; Chao Tian; Iva Gunnarsson; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Michelle Petri; Susan Manzi; Michael F Seldin; Lars Rönnblom; Ann-Christine Syvänen; Lindsey A Criswell; Peter K Gregersen; Timothy W Behrens
Journal:  N Engl J Med       Date:  2008-01-20       Impact factor: 91.245

6.  Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci.

Authors:  John B Harley; Marta E Alarcón-Riquelme; Lindsey A Criswell; Chaim O Jacob; Robert P Kimberly; Kathy L Moser; Betty P Tsao; Timothy J Vyse; Carl D Langefeld; Swapan K Nath; Joel M Guthridge; Beth L Cobb; Daniel B Mirel; Miranda C Marion; Adrienne H Williams; Jasmin Divers; Wei Wang; Summer G Frank; Bahram Namjou; Stacey B Gabriel; Annette T Lee; Peter K Gregersen; Timothy W Behrens; Kimberly E Taylor; Michelle Fernando; Raphael Zidovetzki; Patrick M Gaffney; Jeffrey C Edberg; John D Rioux; Joshua O Ojwang; Judith A James; Joan T Merrill; Gary S Gilkeson; Michael F Seldin; Hong Yin; Emily C Baechler; Quan-Zhen Li; Edward K Wakeland; Gail R Bruner; Kenneth M Kaufman; Jennifer A Kelly
Journal:  Nat Genet       Date:  2008-01-20       Impact factor: 38.330

7.  Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus.

Authors:  Sergey V Kozyrev; Anna-Karin Abelson; Jerome Wojcik; Ammar Zaghlool; M V Prasad Linga Reddy; Elena Sanchez; Iva Gunnarsson; Elisabet Svenungsson; Gunnar Sturfelt; Andreas Jönsen; Lennart Truedsson; Bernardo A Pons-Estel; Torsten Witte; Sandra D'Alfonso; Nadia Barizzone; Nadia Barrizzone; Maria Giovanna Danieli; Carmen Gutierrez; Ana Suarez; Peter Junker; Helle Laustrup; Maria Francisca González-Escribano; Javier Martin; Hadi Abderrahim; Marta E Alarcón-Riquelme
Journal:  Nat Genet       Date:  2008-01-20       Impact factor: 38.330

8.  TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1.

Authors:  Shunbin Ning; Alex D Campos; Bryant G Darnay; Gretchen L Bentz; Joseph S Pagano
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

9.  Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus.

Authors:  Robert R Graham; Chris Cotsapas; Leela Davies; Rachel Hackett; Christopher J Lessard; Joanlise M Leon; Noel P Burtt; Candace Guiducci; Melissa Parkin; Casey Gates; Robert M Plenge; Timothy W Behrens; Joan E Wither; John D Rioux; Paul R Fortin; Deborah Cunninghame Graham; Andrew K Wong; Timothy J Vyse; Mark J Daly; David Altshuler; Kathy L Moser; Patrick M Gaffney
Journal:  Nat Genet       Date:  2008-09       Impact factor: 38.330

10.  Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform.

Authors:  Chaim O Jacob; Andreas Reiff; Don L Armstrong; Barry L Myones; Earl Silverman; Marisa Klein-Gitelman; Deborah McCurdy; Linda Wagner-Weiner; James J Nocton; Aaron Solomon; Raphael Zidovetzki
Journal:  Arthritis Rheum       Date:  2007-12
View more
  23 in total

Review 1.  Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways.

Authors:  Samuel E Vaughn; Leah C Kottyan; Melissa E Munroe; John B Harley
Journal:  J Leukoc Biol       Date:  2012-06-29       Impact factor: 4.962

2.  Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity.

Authors:  Jara K Brenke; Grzegorz M Popowicz; Kenji Schorpp; Ina Rothenaigner; Manfred Roesner; Isabel Meininger; Cédric Kalinski; Larissa Ringelstetter; Omar R'kyek; Gerrit Jürjens; Michelle Vincendeau; Oliver Plettenburg; Michael Sattler; Daniel Krappmann; Kamyar Hadian
Journal:  J Biol Chem       Date:  2018-06-27       Impact factor: 5.157

3.  Association Between TRAF6 Gene Polymorphisms and Susceptibility of Ischemic Stroke in Southern Chinese Han Population.

Authors:  Li Su; Ziwen Chen; Yan Yan; Baoyun Liang; Juanjuan Xie; Qing Chen; Jinjing Tan; Lian Gu
Journal:  J Mol Neurosci       Date:  2015-05-22       Impact factor: 3.444

4.  TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development.

Authors:  Carlo Perricone; Cinzia Ciccacci; Fulvia Ceccarelli; Davide Di Fusco; Francesca Romana Spinelli; Enrica Cipriano; Giuseppe Novelli; Guido Valesini; Fabrizio Conti; Paola Borgiani
Journal:  Immunogenetics       Date:  2013-07-09       Impact factor: 2.846

5.  Regulation of Treg Functions by the Ubiquitin Pathway.

Authors:  Elena Montauti; Deyu Fang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Genetics of Lupus Nephritis: Clinical Implications.

Authors:  Melissa E Munroe; Judith A James
Journal:  Semin Nephrol       Date:  2015-09       Impact factor: 5.299

7.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20

Review 8.  Structural feature of TRAFs, their related human diseases and therapeutic intervention.

Authors:  Hyun Ho Park
Journal:  Arch Pharm Res       Date:  2021-05-10       Impact factor: 4.946

9.  TRAF molecules in cell signaling and in human diseases.

Authors:  Ping Xie
Journal:  J Mol Signal       Date:  2013-06-13

10.  Cachexia in Systemic Lupus Erythematosus: Risk Factors and Relation to Disease Activity and Damage.

Authors:  George Stojan; Jessica Li; Amaya Wittmaack; Michelle Petri
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-10-07       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.